Establishment Labs (NASDAQ:ESTA) Stock Price Down 5.1% - Here's What Happened

Key Points

• Establishment Labs' stock fell by 5.1% during trading on Monday, reaching a low of $41.35, with a significant decrease in trading volume of 61% from its average.
• Despite the drop, multiple analysts have a "Moderate Buy" rating on the stock, with target prices ranging from $47.00 to $62.00, indicating expectations for future growth.
• The company reported revenues of $51.30 million in its latest quarter, marking a year-over-year increase of 16.1%, though it missed EPS estimates with a reported loss of ($0.57).

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) dropped 5.1% during trading on Monday . The stock traded as low as $41.35 and last traded at $41.40. Approximately 204,750 shares changed hands during trading, a decline of 61% from the average daily volume of 528,535 shares. The stock had previously closed at $43.64.

Wall Street Analysts Forecast Growth

ESTA has been the topic of several recent research reports. Canaccord Genuity Group initiated coverage on shares of Establishment Labs in a report on Wednesday, August 20th. They set a "buy" rating and a $60.00 target price on the stock. Wall Street Zen lowered shares of Establishment Labs from a "hold" rating to a "sell" rating in a report on Saturday, August 16th. Needham & Company LLC reaffirmed a "buy" rating and set a $48.00 target price on shares of Establishment Labs in a report on Friday, June 13th. BTIG Research initiated coverage on shares of Establishment Labs in a report on Friday, May 16th. They set a "buy" rating and a $62.00 target price on the stock. Finally, Citigroup increased their target price on shares of Establishment Labs from $38.00 to $47.00 and gave the company a "neutral" rating in a report on Wednesday, July 9th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $56.50.

Establishment Labs Stock Performance

The firm has a market cap of $1.20 billion, a P/E ratio of -13.56 and a beta of 0.83. The company has a current ratio of 2.84, a quick ratio of 1.67 and a debt-to-equity ratio of 9.71. The business's fifty day simple moving average is $40.95 and its 200-day simple moving average is $37.42.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.54) by ($0.03). The firm had revenue of $51.30 million during the quarter, compared to the consensus estimate of $50.80 million. Establishment Labs had a negative return on equity of 224.34% and a negative net margin of 49.89%.Establishment Labs's revenue was up 16.1% on a year-over-year basis. During the same period last year, the business earned ($0.62) EPS. Establishment Labs has set its FY 2025 guidance at EPS. As a group, sell-side analysts expect that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Institutional Investors Weigh In On Establishment Labs

Several institutional investors and hedge funds have recently modified their holdings of ESTA. Adage Capital Partners GP L.L.C. purchased a new stake in shares of Establishment Labs in the 4th quarter worth about $7,261,000. Voya Investment Management LLC lifted its position in shares of Establishment Labs by 7,249.5% in the 4th quarter. Voya Investment Management LLC now owns 408,262 shares of the company's stock worth $18,809,000 after purchasing an additional 402,707 shares during the period. Nebula Research & Development LLC purchased a new stake in shares of Establishment Labs in the 4th quarter worth about $440,000. Aquatic Capital Management LLC lifted its position in shares of Establishment Labs by 173.4% in the 4th quarter. Aquatic Capital Management LLC now owns 10,934 shares of the company's stock worth $504,000 after purchasing an additional 6,934 shares during the period. Finally, Quarry LP purchased a new stake in shares of Establishment Labs in the 4th quarter worth about $27,000. 72.91% of the stock is owned by hedge funds and other institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.